A new study has found that prostate cancer rates are on the rise in men over 50, while rates of early stage prostate cancer have declined.
In 2012, the US Preventive Services Task Force advised against prostate screenings for all, because the risks of the test outweighed the benefits.
By 2017, cases of advanced prostate cancer increased in men 50 and older, while cases of early stage disease declined.